BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 18983611)

  • 1. Stromal cells promote bone invasion by suppressing bone formation in ameloblastoma.
    Sathi GS; Nagatsuka H; Tamamura R; Fujii M; Gunduz M; Inoue M; Rivera RS; Nagai N
    Histopathology; 2008 Oct; 53(4):458-67. PubMed ID: 18983611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parenchyma-stromal interactions induce fibrosis by secreting CCN2 and promote osteoclastogenesis by stimulating RANKL and CD68 through activated TGF-β/BMP4 in ameloblastoma.
    Takebe Y; Tsujigiwa H; Katase N; Siar CH; Takabatake K; Fujii M; Tamamura R; Nakano K; Nagatsuka H
    J Oral Pathol Med; 2017 Jan; 46(1):67-75. PubMed ID: 27327904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.
    Sun SG; Lau YS; Itonaga I; Sabokbar A; Athanasou NA
    J Pathol; 2006 May; 209(1):114-20. PubMed ID: 16482498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative expression of RANK, RANKL, and OPG in keratocystic odontogenic tumors, ameloblastomas, and dentigerous cysts.
    da Silva TA; Batista AC; Mendonça EF; Leles CR; Fukada S; Cunha FQ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Mar; 105(3):333-41. PubMed ID: 18061491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of bone remodeling in neoplastic and bone-related lesions.
    Elias LS; Costa RF; Carvalho MA; Batista AC; Silva TA; Leles CR; Mendonça EF
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Nov; 110(5):624-31. PubMed ID: 20955951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTHrP increases RANKL expression by stromal cells from giant cell tumor of bone.
    Cowan RW; Singh G; Ghert M
    J Orthop Res; 2012 Jun; 30(6):877-84. PubMed ID: 22102368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β-related mechanisms of bone destruction in multiple myeloma.
    Matsumoto T; Abe M
    Bone; 2011 Jan; 48(1):129-34. PubMed ID: 20570621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural and cytobiological studies on possible interactions between PTHrP-secreting tumor cells, stromal cells, and bone cells.
    Ito M; Amizuka N; Tanaka S; Funatsu-Ozawa Y; Kenmotsu S; Oda K; Nakajima T; Ozawa H
    J Bone Miner Metab; 2003; 21(6):353-62. PubMed ID: 14586791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of the fibrous stroma in bone invasion by human gingival squamous cell carcinomas.
    Ishikuro M; Sakamoto K; Kayamori K; Akashi T; Kanda H; Izumo T; Yamaguchi A
    Bone; 2008 Sep; 43(3):621-7. PubMed ID: 18585993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ameloblastoma induces osteoclastogenesis: a possible role of ameloblastoma in expanding in the bone.
    Sandra F; Hendarmin L; Kukita T; Nakao Y; Nakamura N; Nakamura S
    Oral Oncol; 2005 Jul; 41(6):637-44. PubMed ID: 15935726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secreted frizzled related protein (sFRP)-2 inhibits bone formation and promotes cell proliferation in ameloblastoma.
    Sathi GA; Inoue M; Harada H; Rodriguez AP; Tamamura R; Tsujigiwa H; Borkosky SS; Gunduz M; Nagatsuka H
    Oral Oncol; 2009 Oct; 45(10):856-60. PubMed ID: 19362047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor signalling contributes to osteoblastic stromal cell proliferation, osteoclastogenesis and disease progression in giant cell tumour of bone.
    Balla P; Moskovszky L; Sapi Z; Forsyth R; Knowles H; Athanasou NA; Szendroi M; Kopper L; Rajnai H; Pinter F; Petak I; Benassi MS; Picci P; Conti A; Krenacs T
    Histopathology; 2011 Sep; 59(3):376-89. PubMed ID: 22034878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [How is bone formed and resorbed?-- molecular mechanisms of bone formation and resorption].
    Suda T
    Rinsho Byori; 2002 Mar; 50(3):267-72. PubMed ID: 11985054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RANKL signaling in bone physiology and cancer.
    Dougall WC
    Curr Opin Support Palliat Care; 2007 Dec; 1(4):317-22. PubMed ID: 18685382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Melatonin and bone status].
    Ostrowska Z; Wołkowska-Pokrywa K; Kos-Kudła B; Swietochowska E; Marek B; Kajdaniuk D
    Pol Merkur Lekarski; 2006 Oct; 21(124):389-93. PubMed ID: 17205785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases as master regulators of the vicious cycle of bone metastasis.
    Lynch CC
    Bone; 2011 Jan; 48(1):44-53. PubMed ID: 20601294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the biology of bone metastasis: how the skeleton affects tumor behavior.
    Sterling JA; Edwards JR; Martin TJ; Mundy GR
    Bone; 2011 Jan; 48(1):6-15. PubMed ID: 20643235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoblasts and bone formation.
    Caetano-Lopes J; Canhão H; Fonseca JE
    Acta Reumatol Port; 2007; 32(2):103-10. PubMed ID: 17572649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanisms for formation of myeloma bone disease].
    Yata K; Abe M; Matsumoto T
    Clin Calcium; 2008 Apr; 18(4):438-46. PubMed ID: 18379024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD10 expression in stromal cells of ameloblastoma variants.
    Iezzi G; Piattelli A; Rubini C; Artese L; Goteri G; Fioroni M; Carinci F
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Feb; 105(2):206-9. PubMed ID: 17942343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.